以重要残基为导向,合理设计针对 ChtI 的丁烯内酯抑制剂

IF 2.6 4区 医学 Q3 CHEMISTRY, MEDICINAL Medicinal Chemistry Research Pub Date : 2024-04-02 DOI:10.1007/s00044-024-03211-5
Qing Han, Yun-Jiang Zi, Tian-Yu Feng, Nan Wu, Ren-Xuan Zou, Jing-Yu Zhang, Ru-Lei Zhang, Qing Yang, Hong-Xia Duan
{"title":"以重要残基为导向,合理设计针对 ChtI 的丁烯内酯抑制剂","authors":"Qing Han,&nbsp;Yun-Jiang Zi,&nbsp;Tian-Yu Feng,&nbsp;Nan Wu,&nbsp;Ren-Xuan Zou,&nbsp;Jing-Yu Zhang,&nbsp;Ru-Lei Zhang,&nbsp;Qing Yang,&nbsp;Hong-Xia Duan","doi":"10.1007/s00044-024-03211-5","DOIUrl":null,"url":null,"abstract":"<div><p>An effective approach for discovering small molecular inhibitors is the residues-oriented strategy based on enzyme analysis. In this study, we employed a rational approach to design and synthesize a library of butenolide analogues (<b>Ia-f</b> and <b>IIa-f</b>) targeting Trp107, utilizing reported piperonyl butenolide as lead compound. Notably, the most compounds <b>IIa-f</b> (R<sup>2</sup> = NO<sub>2</sub>) exhibited slightly higher inhibitory potency against <i>Of</i> ChtI compared to compounds <b>Ia-f</b> (R<sup>2</sup> = Br). Molecular mechanism studies unveiled a crucial hydrogen bond interaction between the NO<sub>2</sub> group and Trp107, explaining the enhanced binding affinities. Compounds <b>IIe</b> and <b>IIf</b>, both bearing NO<sub>2</sub> on the benzene ring at the R<sup>2</sup> position, displayed the highest inhibitory activity, with <i>K</i><sub>i</sub> values of 0.87 and 0.68 <i>μ</i>M, respectively. Our findings highlight the potential of designing inhibitors with high enzymatic activity by structurally optimizing compounds based on the distinct interaction modes with crucial residues in the binding cavity of <i>Of</i> ChtI.</p></div>","PeriodicalId":699,"journal":{"name":"Medicinal Chemistry Research","volume":"33 5","pages":"740 - 747"},"PeriodicalIF":2.6000,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vital residues-orientated rational design of butenolide inhibitors targeting Of ChtI\",\"authors\":\"Qing Han,&nbsp;Yun-Jiang Zi,&nbsp;Tian-Yu Feng,&nbsp;Nan Wu,&nbsp;Ren-Xuan Zou,&nbsp;Jing-Yu Zhang,&nbsp;Ru-Lei Zhang,&nbsp;Qing Yang,&nbsp;Hong-Xia Duan\",\"doi\":\"10.1007/s00044-024-03211-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>An effective approach for discovering small molecular inhibitors is the residues-oriented strategy based on enzyme analysis. In this study, we employed a rational approach to design and synthesize a library of butenolide analogues (<b>Ia-f</b> and <b>IIa-f</b>) targeting Trp107, utilizing reported piperonyl butenolide as lead compound. Notably, the most compounds <b>IIa-f</b> (R<sup>2</sup> = NO<sub>2</sub>) exhibited slightly higher inhibitory potency against <i>Of</i> ChtI compared to compounds <b>Ia-f</b> (R<sup>2</sup> = Br). Molecular mechanism studies unveiled a crucial hydrogen bond interaction between the NO<sub>2</sub> group and Trp107, explaining the enhanced binding affinities. Compounds <b>IIe</b> and <b>IIf</b>, both bearing NO<sub>2</sub> on the benzene ring at the R<sup>2</sup> position, displayed the highest inhibitory activity, with <i>K</i><sub>i</sub> values of 0.87 and 0.68 <i>μ</i>M, respectively. Our findings highlight the potential of designing inhibitors with high enzymatic activity by structurally optimizing compounds based on the distinct interaction modes with crucial residues in the binding cavity of <i>Of</i> ChtI.</p></div>\",\"PeriodicalId\":699,\"journal\":{\"name\":\"Medicinal Chemistry Research\",\"volume\":\"33 5\",\"pages\":\"740 - 747\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-04-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Chemistry Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00044-024-03211-5\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00044-024-03211-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

摘要 基于酶分析的残基导向策略是发现小分子抑制剂的有效方法。在本研究中,我们以已报道的胡椒基丁烯内酯为先导化合物,采用合理的方法设计并合成了以 Trp107 为靶标的丁烯内酯类似物库(Ia-f 和 IIa-f)。值得注意的是,与化合物 Ia-f(R2 = Br)相比,大多数化合物 IIa-f(R2 = NO2)对 Of ChtI 的抑制效力略高。分子机理研究揭示了 NO2 基团与 Trp107 之间关键的氢键相互作用,从而解释了结合亲和力增强的原因。化合物 IIe 和 IIf 在 R2 位置的苯环上都含有 NO2,显示出最高的抑制活性,Ki 值分别为 0.87 和 0.68 μM。我们的研究结果凸显了根据化合物与 Of ChtI 结合腔中关键残基的不同相互作用模式对化合物进行结构优化,从而设计出具有高酶活性的抑制剂的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Vital residues-orientated rational design of butenolide inhibitors targeting Of ChtI

An effective approach for discovering small molecular inhibitors is the residues-oriented strategy based on enzyme analysis. In this study, we employed a rational approach to design and synthesize a library of butenolide analogues (Ia-f and IIa-f) targeting Trp107, utilizing reported piperonyl butenolide as lead compound. Notably, the most compounds IIa-f (R2 = NO2) exhibited slightly higher inhibitory potency against Of ChtI compared to compounds Ia-f (R2 = Br). Molecular mechanism studies unveiled a crucial hydrogen bond interaction between the NO2 group and Trp107, explaining the enhanced binding affinities. Compounds IIe and IIf, both bearing NO2 on the benzene ring at the R2 position, displayed the highest inhibitory activity, with Ki values of 0.87 and 0.68 μM, respectively. Our findings highlight the potential of designing inhibitors with high enzymatic activity by structurally optimizing compounds based on the distinct interaction modes with crucial residues in the binding cavity of Of ChtI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicinal Chemistry Research
Medicinal Chemistry Research 医学-医药化学
CiteScore
4.70
自引率
3.80%
发文量
162
审稿时长
5.0 months
期刊介绍: Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of molecular biology.
期刊最新文献
Synthesis of new Michael acceptors with cinnamamide scaffold as potential anti-breast cancer agents: cytotoxicity and ADME in silico studies Iridoid for drug discovery: Structural modifications and bioactivity studies Synthesis and antiproliferative activity of 7-substituted amide estradiol derivatives Correction: Substituted furan-carboxamide and Schiff base derivatives as potential hypolipidemic compounds: evaluation in Triton WR-1339 hyperlipidemic rat model Quinazolinone-based subchemotypes for targeting HIV-1 capsid protein: design and synthesis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1